Your institution may have access to this item. Find your institution then sign in to continue.
Title
Myriad receives patent for BRCA1 mutations.
Abstract
Notes that Myriad Genetics, Salt Lake City, Utah, was awarded a patent on 47 different mutations in the BRCA1 gene in December, 1997. Gene's tie to breast and ovarian cancer; Myriad's lawsuit against Oncormed, Gaithersburg, Maryland.